Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three active ingredients—potassium nitrate, strontium chloride, and paeonol—primarily formulated as a toothpaste for the management of dentine hypersensitivity (DH). Potassium nitrate acts by depolarizing nerve endings in the dental pulp to reduce pain transmission. Strontium chloride works by occluding dentinal tubules, thereby blocking external stimuli from reaching nerves. Paeonol is a natural compound with anti-inflammatory and analgesic properties, derived from the root bark of Paeonia suffruticosa. Clinical trials have demonstrated that this combination significantly reduces symptoms of dentine hypersensitivity compared to placebo toothpaste[1][2][3]. The product is considered a novel functional ingredient blend for anti-hypersensitivity oral care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium nitrate + strontium chloride + paeonol.